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Temperature-sensitive polymeric micelles were prepared from dextran grafted with poly(N-
isopropylacrylamide) (PNIPAAm) or polyethylene glycol methyl ether (PEGMA) via controlled radical
polymerization and evaluated as delivery systems of the anticancer drug methotrexate (MTX). Polymer-
grafting was carried out after introduction of initiating groups onto the polysaccharide backbone,
without the need for protection of hydroxyl groups and avoiding the use of toxic solvents. Temperature-
responsive dextran-based copolymers were designed to exhibit self-aggregation behaviour, aﬃnity for
MTX and high cellular internalization. In addition, some grafted polymers incorporated 2-aminoethyl
methacrylate to reinforce MTX encapsulation in the micelles by means of ionic interactions. Dextran-
based micelles were cytocompatible and had an appropriate size to be used as drug carriers. MTX
release was dependent on the pH and temperature. The combination of poly(2-aminoethylmethacrylate)
and PNIPAAm with the dextran backbone permitted the complete release of MTX at normal
physiological temperature. Co-polymer micelles were highly internalized by tumour cells (CHO-K1) and,
when loaded with MTX, led to enhanced cytotoxicity compared to the free drug.Introduction
Methotrexate (MTX) is one of the most eﬀective drugs in the
treatment of a variety of solid tumours, hematologic malignan-
cies, psoriasis and rheumatoid arthritis.1 This folic acid analogue
inhibits dihydrofolate reductase and other folate-dependent
enzymes, resulting in the interruption of DNA and RNA
synthesis and adenosine overproduction. Importantly, MTX
exploits folate-receptors to allow absorption across the gut aer
oral administration and for intracellular accumulation in tumour
tissue. However, folate-receptors can become saturated before the
uptake of a required therapeutic dose.2 This problem, together
with certain side eﬀects, such as bone marrow suppression,
hepatotoxicity, leukopenia and nephrotoxicity, have prompted themace´utica, R+DPharma Group (GI-1645),
tiago de Compostela, 15782 Santiago de
z.lorenzo@usc.es; Web: barbara.blanco.
ngham, University Park, Boots Science
ESI) available: Hydrodynamic radius of
–PNIPAAm–AEM, dextran–PEGMA and
(0.5 mg mL1) at 20, 37 and 55 C
hs of dextran–PNIPAAm–AEM at 20 C
696a
logy, Michigan State University, East
niversity of Birmingham, Birmingham
0search for nanocarriers that use other pathways for cell internal-
ization and which selectively deliver MTX to target cells. Nano-
emulsions,3 nanoparticles,4 liposomes,5 and polymeric micelles6,7
have been tested as suitable MTX delivery systems. If adequately
designed, polymeric micelles can encapsulate large amounts of
poorly soluble drugs,8–11 prevent premature leakage in the blood
stream,12–15 and facilitate accumulation in tumour and inamed
tissues as a consequence of the enhanced permeation and
retention (EPR) eﬀect.16–18 Furthermore, amphiphilic copolymers
can be adapted with stimuli-responsiveness to aﬀord better
control of drug loading and release processes.15,19,20 Established
tumour tissues are in general characterized by a decrease in pH,
an increase in glutathione levels, and a slightly higher tempera-
ture than healthy tissues, which can be exploited for enhanced
delivery of anticancer drugs.21,22
Hybrid materials that combine natural and synthetic poly-
mers are receiving increasing attention as components of drug
and gene delivery systems. Polysaccharides are good candidates
for biomaterials due to their biocompatibility, solubility in
water, degradability in the environment, low cost and avail-
ability from renewable sources.23 However, not all poly-
saccharides are readily amenable for systemic drug delivery
owing to a lack of aﬃnity for drug molecules or functionality for
amphiphile formation. Growing a synthetic polymer which is
reversibly amphiphilic from a polysaccharide backbone poten-
tially enables formation of much more versatile drug carriers.
Controlled radical chemistries, such as atom transfer radical
polymerization (ATRP), reversible addition–fragmentationThis journal is © The Royal Society of Chemistry 2017
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View Article Onlinechain transfer (RAFT), nitroxide-mediated polymerization
(NMP) or cyanoxyl-mediated free radical polymerization, allows
tuneable and repeatable preparation of a variety of amphiphilic
derivatives of polysaccharides.24 As a polysaccharide core
dextran is a highly suitable candidate for chemical derivatiza-
tion, as it is biocompatible and is already used as a plasma
volume expander and antithrombotic agent. Dextran consists of
glucose units linked through a-1,6 bonds with some a-1,2, a-1,3
and a-1,4 modications, providing numerous hydroxyl groups
for derivatization. Hydrophobic chains,25–27 stimuli-sensitive
chains/groups28–31 and a number of drugs32 have been graed
to dextran to obtain self-assembling derivatives. So far, attempts
to apply controlled radical polymerisation for the preparation of
amphiphilic copolymers of dextran have required the use of
toxic solvents or the protection of specic hydroxyl groups to
introduce initiating groups onto the polysaccharide back-
bone.33–35 For example, synthesis of poly(N-isopropylacrylamide)
(PNIPAAm)-gra dextran involved dimethylformamide and
LiCl.36 RAFT-graing of poly(ethylene glycol) methyl ether
methacrylate (PEGMA) onto dextran has been explored to obtain
micelles able to encapsulate doxorubicin for treatment of
neuroblastoma cancer cells.29 Copolymers of dextran graed
with poly(lactobionamidoethyl methacrylate) and di(ethylene
glycol) methyl ether methacrylate were able to form micelles
which recognized a lectin for targeted delivery.37
In the present work, PNIPAAm-graed dextran and PEGMA-
graed dextran copolymers were synthesised using controlled
radical polymerisation following the introduction of initiating
groups into the polysaccharide backbone without the protection
of hydroxyl groups and under mild conditions. The nal aim of
the work was to obtain temperature-responsive copolymers that
exhibit self-aggregation features, aﬃnity for MTX and high
cellular internalization. PNIPAAm was chosen due to its widely-
used lower critical solution temperature (LCST) properties in
aqueous medium (close to 32 C).38 For comparison, PEGMA
macromonomers were selected to enable the preparation of
more cytocompatible copolymers with tuneable LCST by
combining macromonomers of diﬀerent molar masses.39,40 2-
Aminoethyl methacrylate (AEM) was also copolymerized as
a way to endow the copolymers with enhanced aﬃnity for MTX
in order to overcome the low loading content (LC 2–5%) that is
commonly observed in polymeric micelles for this drug.15,41,42
Moreover, polyAEM components were also expected to enhance
cellular uptake due to the presence of positive charges in the
polymer chains. The obtained polymeric micelles were charac-
terized regarding their suitability as MTX delivery systems,
critical micellar concentration, micelle size, surface charge and
cytocompatibility. The eﬀects of temperature and pH on drug
release were evaluated, and the eﬀectiveness of the MTX-loaded
micelles and their cellular internalization in cancer cell lines
were investigated.
Materials and methods
Materials
4-(Dimethylamino) pyridine (DMAP) was obtained from Fluka
(China). L-Ascorbic acid sodium salt (99%) and methotrexateThis journal is © The Royal Society of Chemistry 2017(MTX) were from Acros Organics (Belgium) and AK Scientic
(USA) respectively. Dextran from Leuconostoc spp. (40 kDa),
dimethyl sulfoxide anhydrous (DMSO), phosphate buﬀer
saline pH 7.4 (PBS), a-bromoisobutyryl bromide (BiBB), cop-
per(II) bromide (CuBr2, 99%), copper(I) bromide (CuBr, 99%),
pyrene, Dulbecco's modied Eagle medium F-12 Ham
(DMEM-F12 Ham), fetal bovine serum (FBS), 2,20-dipyridyl
(Bpy, 99%), 2-aminoethyl methacrylate (AEM, 99%), N-iso-
propylacrylamide (NIPAAm), di(ethylene glycol) methyl ether
methacrylate (PEGMA 188 monomer, Mn 188.22), poly(-
ethylene glycol) methyl ether methacrylate (PEGMA 475
monomer, Mn 475) and uorescein isothiocyanate (FITC)
were from Sigma Aldrich (St. Louis, MO, USA). NIPAAm was
recrystallized with hexane prior use. PEGMA 188 and 475
monomers were puried before use by passing through
a column of neutral alumina. Tris(2-pyridyl) methylamine
(TPMA) was prepared as described previously.43 Dialysis
membranes (MWCO 50 kDa, 25 kDa, 15 kDa and 3.5 kDa) and
Float-A-Lyzer G2 (8–10 kDa, 1 mL, cellulose ester) were from
Spectra/Por (Fisher Scientic, USA). RPMI 1640 without folic
acid and penicillin (10 000 units per mL)/streptomycin
(10 000 mg mL1) were from Invitrogen (USA). ProLong®
Gold Antifade Reagent with DAPI and Phalloidine (Biodipy®
650/665) were from Life Technologies (USA). Phosphate buﬀer
pH 5.5 was prepared as described in the European Pharma-
copeia. Puried water (Milli-Q system, Millipore; resistivity >
18.2 MU cm) was used in all the experiments. Other solvents
were analytical grade and purchased from Sigma Aldrich (St.
Louis. MO, USA).Synthesis and characterization of dextran copolymers
Synthesis of dextran macroinitiators. Dextran macro-
initiators were prepared by dissolving dextran (500 mg) and
DMAP (1.24 g; 1.2 eq. per eq. of hydroxyl group) in 20 mL
anhydrous DMSO over 1 h under N2 atmosphere at room
temperature. Aerwards, the solution was cooled down in an ice
bath and BiBB (0.2 eq. for dextBr0.2 eq., 0.4 eq. for dextBr0.4
eq., or 0.8 eq. for dextBr0.8 eq. per eq. of hydroxyl group) was
added dropwise (Fig. 1 and 2). Aer 30minutes, the ice bath was
removed, and the reaction was allowed to proceed at room
temperature during 21.5 h. Then, the solution was diluted with
water (180 mL), dialyzed against water (MWCO 15 kDa) over 4
days and freeze-dried. The extent of molar substitution was
estimated by 1H-NMR in DMSO-d6 (400 MHz, Bruker, UK)
(overall yield > 90% in every macroinitiator).
Synthesis of dextran–PNIPAAm. DextBr0.4 eq. (65 mg;
0.072 mmol of functional groups) was dissolved in water (10
mL) and then NIPAAm (480 mg; 59.4 eq.) and CuBr (10.3 mg; 1
eq.) were added to prepare dextran–PNIPAAm copolymer.
Subsequently, the solution was degassed with argon for 20
minutes and put in an ice bath. Bpy (56.1 mg; 5 eq.) was added
under an argon atmosphere. The reaction was stopped (opening
it into the air) aer 5 h (approximately 70% conversion as
estimated by 1H-NMR (400MHz) in D2O).44 Then, solutions were
dialyzed against water (MWCO 15 kDa) over 4 days and freeze-
dried (nal yield 30%).RSC Adv., 2017, 7, 14448–14460 | 14449
Fig. 1 Schematic of the synthesis of dextran grafted with thermor-
esponsive polymers (PEGMA, PEGMA–AEM, PNIPAAm and PNIPAAm–
AEM) by means of controlled radical polymerization starting from
a dextran macroinitiator.
Fig. 2 1H-NMR spectra of dextran and dextran macroinitiators
(dextBr0.2 eq., dextBr0.4 eq. and dextBr0.8 eq.) in DMSO-d6.
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View Article OnlineSynthesis of dextran–PNIPAAm–AEM. DextBr0.4 eq. (65 mg;
0.072 mmol of functional groups) was dissolved in water (10
mL) and NIPAAm (400 mg; 48.74 eq.), AEM (44.30 mg; 3.70 eq.)
and CuBr (10.30 mg; 1 eq.) were added. Subsequently, the
solutions were degassed with argon for 20 minutes and put in
an ice bath. Bpy (56.1 mg; 5 eq.) was added under an argon
atmosphere. The reaction was stopped by opening the ask to
air aer 5 h (approximately 70% conversion as estimated by 1H-
NMR in D2O).44 Then, solutions were dialyzed against water
(MWCO 15 kDa) over 4 days and freeze-dried (nal yield 47%).
Synthesis of dextran–PEGMA. PEGMA-based polymers were
prepared adapting a previously reported methodology.40
DextBr0.4 eq. (65 mg; 0.072 eq. of functional groups) was dis-
solved in 10 mL of PBS pH 7.4. CuBr2 (16.1 mg; 1 eq.), TPMA
(20.9 mg; 1 eq.), PEGMA 188 monomer (1.22 g; 90.4 eq.) and14450 | RSC Adv., 2017, 7, 14448–14460PEGMA 475 monomer (220 mg; 6.3 eq.) were added to the
solution. Subsequently, the solution was degassed with argon
for 20 minutes and put in an ice bath. Ascorbic acid (2.4 mg;
0.17 eq.) was added under an argon atmosphere. The reaction
was stopped by exposure to atmospheric oxygen aer 3.5 h
(approximately 70% of conversion as estimated by 1H-NMR).40
Then, the solutions were dialyzed against water (MWCO 15 kDa)
during 4 days and freeze-dried (nal yield: 75%).
Synthesis of dextran–PEGMA–AEM. DextBr0.4 eq. (65 mg;
0.072 eq. of functional groups), CuBr2 (16.1 mg; 1 eq.) and
TPMA (20.9 mg; 1 eq.) were dissolved in 10 mL of PBS pH 7.4.
Then, PEGMA 188 (1.01 g; 74.73 eq.), PEGMA 475 (108 mg; 5.22
eq.) monomers and AEM (30.4 mg; 2.55 eq.) were added to it.
Subsequently, the solution was degassed with argon for 20
minutes and put in an ice bath. Ascorbic acid (2.4 mg; 0.17 eq.)
was added under argon and the reaction was stopped aer 3.5 h
(approximately 70% conversion by 1H-NMR).40 Then, the solu-
tions were dialyzed against water (MWCO 15 kDa) during 4 days
and freeze-dried (nal yield 55%).
Molecular weight and LCST determination. Molecular
weights of dextBr0.4 eq., dextran–PNIPAAm and dextran–PNI-
PAAm–AEM were determined by means of a Polymer Labs GPC
50 Plus system tted with a diﬀerential refractive index detector.
Two PL gel mixed-D columns (300  7.8 mm, 5 mm bead size,
Polymer Labs, UK) tted with a matching guard column (50 
7.8 mm) were employed for the separations. DMF with 0.1%
LiBr was the mobile phase at a ux of 1 mL min1, and PMMA
standards (160 Da to 240 kDa, Polymer Labs, UK) were used for
the column calibration. Molecular weights of dextran and
dextBr0.4 eq. were estimated by means of aqueous GPC using
a Shimadzu UPLC system tted with a diﬀerential refractive
index detector. The mobile phase consisted on Dulbecco's PBS
without Ca2+ and Mg2+ (DPBS, Lonza, USA) at 30 C at 1 mL
min1. A Polymer Labs aquagel-OH guard column (50  7.5
mm, 8 mm) followed by a pair of PL aquagel-OH columns (30
and 40, 300  7.5 mm, 8 mm) was used. Calibration was done
with PEG/PEO standards (200 Da to 130 kDa). Shimadzu Lab
Solutions soware was used for determining the molar masses
and the mass dispersities.
Cloud points of polymers in solution were used as approxi-
mations of the lower critical solution temperatures (LCST) of
the polymers. Absorbances of aqueous solutions of the macro-
initiator and copolymers in PBS pH 7.4 (1 mg mL1) were
recorded at 550 nm (Beckman DU 640 UV, USA) in the 20–50 C
range. The temperature was controlled using a Peltier plate
heating system and it was increased at a rate of 1 C min1.
LCST was estimated as the temperature at which the trans-
mittance was 50% of the initial one.Micelle characterization
The zeta-potentials of the copolymers (1 mgmL1) in water were
measured using a Zetasizer (Nano series, Malvern, UK). Critical
micellar concentrations (CMC) of dextBr0.4 eq. and copolymers
was determined using pyrene as a uorescent probe. Aliquots of
pyrene solution in acetone (50 mL, 50 mg mL1) were added to
Eppendorf vials and acetone was allowed to evaporate. Then,This journal is © The Royal Society of Chemistry 2017
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View Article Onlinesolutions (1 mL) of each polymer prepared in PBS pH 7.4 at
various concentrations (1, 5, 10, 25, 50, 75, 100, 250, 500, 750
and 1000 mg mL1) were added. The solutions were kept at 37 C
overnight and the uorescence was measured using an emis-
sion wavelength of 390 nm and recording the excitation in the
250–360 nm range (Cary Eclipse, Varian, USA, equipped with
a thermostated cell compartment). The same solutions were
kept for a further 12 h at room temperature and the uores-
cence was measured again.
The hydrodynamic radii of the polymeric micelles (0.5 mg
mL1) were measured using dynamic light scattering (DLS,
Viscotek DLS, Malvern Omnisize 3.0, UK) with an incident laser
(50 mW, 830 nm) at 90 angle at 20, 37 and 50 C. The radius
was calculated from the measured diﬀusions coeﬃcients (D)
applying the Stokes–Einstein equation (eqn (1)) assuming
spherical shape and non-interaction between the micelles:
RH ¼ kT
6phD
(1)
In this equation, RH represents the hydrodynamic radius, k
the Boltzmann constant, T absolute temperature, and h solvent
viscosity. Measurements quoted are the averages of triplicate
measurements of 3 diﬀerent samples with at least 10 readings
of particle size of copolymer solutions in PBS pH 7.4. The radii
of the self-assembled structures correspond to those scattering
more than 75% of the light.
Atomic force microscopy (AFM) images of dextran–PNI-
PAAm–AEM micellar solution were recorded using liquid
imaging on a MultiMode 8 Scanning Probe Station with nano-
ScopeIIIa controller (Bruker, USA) at room temperature and
37 C. The surface was coated with 10 mMmagnesium chloride
prior to sample deposition. Copolymer solutions (10 mg mL1)
were made up in ltered (0.45 mm) PBS at pH 7.4. Images were
analysed using particle size analysis by NanoScope Analysis
soware (version 1.20, Bruker, USA).
In vitro cell viability studies were performed using BALB/
3T3 (clone A31, ATCC® CCL-163™) cells. Aliquots (100 mL)
of a cell suspension (200 000 cell per mL) in DMEM-F12 Ham,
supplemented with 10% FBS and 1% solution of penicillin
(10 000 units per mL)/streptomycin (10 000 mg mL1), were
seeded into 96-well plates and incubated over 24 h at 37 C, 5%
CO2 and 90% RH. Solutions of dextran, dextran–PNIPAAm,
dextran–PNIPAAm–AEM, dextran–PEGMA and dextran–
PEGMA–AEM in cell medium were prepared, and 100 mL of
each one was added to the cells to have nal concentrations of
0.001, 0.01, 1, 2.5, 10, 25, 50, 100, 200, 300, 400, 500, 750 and
1000 mg mL1 in the wells. Plates were incubated at 37 C for 24
and 48 h in 5% CO2 and 90% RH. Cell viability was analyzed
following the instructions of a MTT kit supplier (Roche,
Switzerland) using an ELISA plate reader (BIORAD Model 680
Microplate Reader, USA) with a 550 nm lter (Abssample).
Negative controls were also tested by adding fresh medium to
the wells and treating them in the same way as the samples
(Abscontrol). The tests were carried out in triplicate. The meta-
bolic activity as a proxy for cell viability (%) was quantied as
follows (eqn (2)):This journal is © The Royal Society of Chemistry 2017Cell viabilityð%Þ ¼ Abssample
Abscontrol
 100 (2)
Preparation of methotrexate-loaded micelles and “in vitro”
drug release
MTX-loaded micelles were prepared applying two diﬀerent
approaches: dialysis or solvent evaporation. All tests were per-
formed in triplicate. The dialysis method consisted in incu-
bating each copolymer solution (0.5 mL, 30 mgmL1) with MTX
(0.5 mL, 6 mg mL1) in PBS pH 7.4 or phosphate buﬀer pH 5.5
for 2.5 h at 37 C. Aerwards, solutions were poured in Float-A-
Lyzer dialysis devices (MWCO 8–10 kDa) and dialyzed against
water at 37 C during 24 h, replacing the water four times (aer
2, 4, 6 and 10 h). Then, samples of 125 mL were removed from
the content of the dialysis tubes, diluted with 375 mL of PBS pH
7.4, and 0.5 mL of DMSO was added to disrupt the micelles.
Drug loading content (L.C.) and encapsulation eﬃciency (E.E.)
were determined as follows:
L:C: ¼ mass of MTX loaded
mass of polymer
 100 (3)
E:E: ¼ mass of MTX loaded
mass of MTX added
 100 (4)
For the solvent evaporation approach, copolymer solutions
in THF (1 mL, 60 mg mL1) were stirred over 2 h with 12 mg of
MTX at room temperature. Then, THF was allowed to evaporate
overnight, and the formed lm was incubated in 1 mL of PBS
pH 7.4 at 37 C for 2.5 h under magnetic stirring. The systems
were centrifuged (8500 rpm, 20 min) to remove non-dissolved
drug, and then the supernatant was freeze-dried. Freeze-dried
samples (1 mg) were used to estimate the encapsulation eﬃ-
ciency (eqn (4)) and the loading content (L.C.; eqn (5)).
L:C: ¼ mass of MTX loaded
mass of freeze dried powder 100 (5)
MTX release experiments were carried out at various pH and
temperature conditions. In order to check the eﬀect of the pH,
dispersions (2 mL) of MTX-loaded micelles (prepared applying
the dialysis method) were added into Float-A-Lyzer dialysis
devices (8–10 kDa), which were then placed in 80 mL of PBS pH
7.4 or phosphate buﬀer pH 5.5 at 37 C. Regarding the eﬀect of
the temperature, freeze-dried MTX-loaded micelles (5 mg;
solvent evaporation method) were reconstituted in 2 mL of PBS
pH 7.4 and added into Float-A-Lyzer dialysis devices (8–10 kDa).
The devices were immersed in 30 mL of PBS pH 7.4 at 37 or
40 C, under magnetic stirring. At preestablished times,
samples (1 mL) of the release medium were taken to determine
MTX concentration and replaced with the same volume of fresh
medium. Amounts of MTX loaded and released were deter-
mined using a HPLC equipment tted with a Controller 600
pump, an autosampler 717, photodiode array detector (996 PDA
detector) and Empower 2000 soware (Waters, USA). An
Atlantis® dC18 (5 mm, 4.6  250 mm, Waters, Ireland) columnRSC Adv., 2017, 7, 14448–14460 | 14451
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View Article Onlinemaintained at 40 C was used. The mobile phase was water-
: acetonitrile mixture (90 : 10 v/v) at 1.2 mL min1. MTX was
quantied at 302 nm.
Cytotoxicity of methotrexate-loaded and non-loaded micelles
HeLa (ATCC® CCL-2™) and CHO-K1 (ATCC® CCL-61™) cells
suspensions (200 000 cells per mL) in RPMI 1640 without folic
acid, supplemented with 10% FBS and 1% solution of penicillin
(10 000 units per mL)/streptomycin (10 000 mg mL1) were
seeded in 96-well plates (100 mL) and incubated over 24 h at
37 C, 5% CO2 and 90% RH. Micellar solutions were prepared
with and without MTX using copolymer concentration 2-fold
above CMC (CMCx2). Pristine dextran was tested at 400 mg
mL1. MTX-loaded micelles were prepared following the two
methods described above, with an additional step of freeze-
drying in all cases, and reconstitution in the culture medium.
The cell medium of the wells was replaced by the micellar
solutions (200 mL). Plates were incubated at 37 C for 24 and
48 h in 5% CO2 and 90% RH. Cell viability was analyzed
following the instructions of a MTT kit supplier (Roche, Swit-
zerland) using an ELISA plate reader (BIORAD Model 680
Microplate Reader, USA) with a 550 nm lter. Cytocompatibility
(%) was quantied using eqn (2). All tests were carried out in
triplicate. Negative controls were also performed by adding
fresh medium alone to the wells and treating them in the same
way as the samples.
Cellular uptake
FITC-labeled polymers were prepared as described before for
dextran micelles.45 Briey, FITC (2 mg mL1 in ethanol, 0.5 mL)
was added to copolymer (dextran–PNIPAAm, dextran–PNI-
PAAm–AEM, dextran–PEGMA or dextran–PEGMA–AEM) solu-
tions in water (10 mg in 1 mL). The reaction mixture was stirred
at room temperature over 24 h, and dialyzed against water
(MWCO 3.5 kDa) for 48 h to remove ethanol and unreacted
FITC. Labelled copolymers were freeze-dried. The whole exper-
iment was done protecting samples from the light.
CHO-K1 cells (500 000 cell per mL, 100 mL) in RPMI without
folic acid supplemented with 10% FBS and 1% solution of
penicillin (10 000 units per mL)/streptomycin (10 000 mg mL1)
were seeded in 8-well glass plates (0.7 cm2, Millicell® EZ slide,
Millipore, USA) and 338 mL of fresh medium was added. Aer
24 h of incubation (37 C, 5% CO2 and 90% RH), the cells
medium was removed and replaced by 438 mL of the FITC-
labelled copolymer solutions in culture medium (500 mg mL1
or 2-fold CMC) or fresh medium. The cells were incubated with
the micelles for 2 h and 24 h at 37 C. Subsequently, themicellar
solutions were removed, and the cells were washed three times
with PBS pH 7.4. Then, cells were xed with paraformaldehyde
(100 mL, 4% w/v in PBS pH 7.4) over 20 min at room temperature
and washed again with PBS three times. Cells were incubated
with Triton X-100 (50 mL, 0.2% w/v in PBS) for 5 min at room
temperature, and washed again with PBS pH 7.4 three times.
Phalloidin solution (30 mL, 75 nM in PBS pH 7.4) was added and
cells were incubated for 20 minutes at room temperature.
Aerwards, cells were washed again with PBS pH 7.4 three times14452 | RSC Adv., 2017, 7, 14448–14460and the upper part of the well glass was removed ready for being
visualized under confocal microscopy. A drop of ProLong® Gold
Antifade Reagent with DAPI was added to each well, and the
glass slide was frozen at 20 C over night to enhance the
uorescent dye penetration inside cells. Confocal images of
samples incubated for 2 h and for 24 h were recorded using
a 63 objective in a TCS SP5 AOBS and in a TCS SP2 spectral
confocal system (Leica Microsystems, Germany), respectively.
Fluorescent signals were collected using a sequential acquisi-
tion mode. Green channel was used for FITC-labeled micelles
(lexc ¼ 488 nm, lem ¼ 511–563 nm), red channel for phalloidin
(lexc ¼ 561 nm, lem ¼ 577–700 nm) and blue channel for DAPI
(lexc ¼ 405 nm, lem ¼ 425–475 nm).Results and discussion
Synthesis of dextran copolymers
Comb-shaped temperature-sensitive dextran copolymers were
synthesized according to a “graing from” technique. First,
bromoisobutyrate initiating groups were introduced onto the
dextran backbone to obtain a dextran macroinitiator. Unlike
previous attempts to prepare dextran macroinitiators that
required protection of hydroxyl groups,33,46 the polysaccharide
macroinitiator was prepared by direct esterication using BiBB
in the presence of DMAP in DMSO (Fig. 1). This solvent was
previously used to introduce ATRP initiating groups in dextran
particles using BiBB and triethylamine as a base35 or in soluble
dextran polymer using 2-bromo-2-methylpropionic acid and 1,10
carbonyldiimidazole/DMAP.37 Triethylamine was tested initially
as the base in this study, but in our case greater substitution
was achieved with DMAP. Diﬀerent BiBB ratios (0.2, 0.4 or 0.8
eq. per hydroxyl group) were tested in order to have diﬀerent
proportions of alkyl halide initiators on the backbone. Graing
was expected to occur at the hydroxyl groups in positions 2 and
3 due to the higher basicity; however, steric repulsion may have
facilitated the substitution in position 3. The degree of molar
substitution (the number of BiBB groups per 100 glucose units)
of each macroinitiator was calculated from 1H-NMR spectra in
DMSO-d6, by integrating the signal at 1.9 ppm (A1.9) corre-
sponding to the six protons of the methyl groups of BiBB and
the signal at 4.4–5.7 (A4.4–5.7) which corresponds to the
anomeric proton and the three hydroxyl protons of the dextran
(Fig. 2). However, due to the disappearance of the signal of
hydroxyl protons aer reaction with BiBB, this value had to be
corrected with the signal from the BiBB. The degree of substi-
tution was calculated as indicated in eqn (6).
Degree of substitution ¼
A1:9
6
A4:45:7  3 A1:9
6
4
þ A1:9
6
 100 (6)
Substitution values were 9% for dextBr0.2 eq., 21% for
dextBr0.4 eq. and 31% for dextBr0.8 eq. DextBr0.2 eq. and
dextBr0.8 eq. were discarded for the synthesis of the
temperature-sensitive polymers due to the small proportion ofThis journal is © The Royal Society of Chemistry 2017
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View Article Onlineinitiating groups graed and the poor aqueous solubility of the
macroinitiator, respectively.
The molecular weights of the polysaccharide and dextBr0.4
eq. were determined by means of GPC using DPBS and DMF as
solvents, respectively. Dextran molecular weight estimated by
GPC was around 23 kDa with moderate polydispersity (Mw 23.0
kDa, Mn 13.0 kDa; Đ ¼ 1.8). The GPC-derived molecular weight
of the macroinitiator in DMF was slightly lower than that of the
pristine polysaccharide (Mw ¼ 17.0 kDa;Mn¼ 9.9 kDa; Đ ¼ 1.7),
which may have been a consequence either of a diﬀerent chain
conformation in solution compared to the unsubstituted
dextran or some partial chain cleavage due to acid generation
during substitution.Fig. 3 Temperature-transmittance curves of dextran macroinitiator
(dextBr0.4 eq.), dextran–PNIPAAm, dextran–PNIPAAm–AEM, dextran–
PEGMA and dextran–PEGMA–AEM (1000 mg mL1) in PBS pH 7.4. The
cloud points were deﬁned as the onset of a non-linear change in
turbidity.Synthesis of temperature-sensitive dextran-based copolymers
Temperature-sensitive copolymers were prepared as summa-
rized in Fig. 1. For ATRP, DextrB0.4 eq. was used as macro-
initiator. For preparing dextran–PNIPAAm, CuBr was used as
a catalyst, Bpy as ligand and water as solvent. The reaction was
monitored by 1H-NMR in D2O until 70% conversion was ach-
ieved (ca. 5 h), aimed to provide PNIPAAm gra chains with
a theoretical molecular weight of 4.7 kDa. The weight average
molecular weight of the resultant dextran–PNIPAAm conjugate
determined by GPC in DMF was 110 kDa (Mw¼ 110.3 kDa;Mn¼
36.8 kDa; Đ ¼ 3.0). The high polydispersity was likely a conse-
quence of inherent molecular weight range of the native poly-
saccharide, as well as limited control of the gra
polymerization. It should also be noted that the molecular
weight of comb- and brush-type polymers is oen under-
estimated by GPC because linear standards are generally used
for calibration,47 thus, the true molecular weight of the copol-
ymer was likely be higher than that estimated by GPC. However,
as we were interested in relative rather than absolute molecular
weights, further characterisation was not considered necessary.
The synthesis of poly(ethylene glycol) polymers by ATRP
using poly(ethylene glycol) alkyl ether methacrylates as starting
materials has been previously reported.41 We adapted this
methodology, but using dextBr0.4 eq. as initiator. TPMA, CuBr,
ascorbic acid and PBS pH 7.4 were used as ligand, catalyst,
reducing agent and solvent, respectively. The reaction was also
monitored by 1H-NMR in chloroform-d, until 70% conversion
was achieved (approximately 3.5 h) to obtain theoretical PEGMA
gras of 14 kDa. The molecular weight could not be determined
by GPC due to the poor solubility in chloroform and DMF, and
the high aﬃnity of the polymers for the stationary phase of the
aqueous GPC. Attempts to determine molecular weight by
MALDI-TOF were also not successful (data not shown).
Temperature-responsiveness of the graed-copolymers was
demonstrated by monitoring the transmittance of the solutions
with increasing temperature (Fig. 3). Both pristine dextran and
dextran macroinitiator did not show temperature-responsiveness,
while dextran–PNIPAAm showed a cloud point of 35 C, which is
slightly higher than the reported LCST of PNIPAAm. The diﬀer-
ence in phase transition temperature of the conjugate compared
to that expected for pure PNIPAAm can be attributed partially to
the hydrophilic environment provided by dextran.47 This wasThis journal is © The Royal Society of Chemistry 2017likely to have altered the extent to which the PNIPAAm chains
were able to associate and thus self-aggregate, and it is important
to note that cloud point is a concentration-dependent phenom-
enon, whereas the true LCST of a polymer chain is concentration-
independent. Therefore, even if the PNIPAAm graed chains were
exhibiting an LCST at 32 C, it may only have been apparent at
several degrees above this temperature that the conjugate chains
could associate suﬃciently to reach a cloud point. The measured
cloud point of the analogous dextran–PEGMA conjugate was
34 C, again indicative of temperature-induced self-association of
hydrophobic chains, and again within a temperature region
appropriate for biomedical purposes. Dextran–PEGMA–AEM and
dextran–PNIPAAm–AEM were prepared by controlled free radical
polymerisation following the same protocol used for the synthesis
of dextran–PEGMA and dextran–PNIPAAm respectively, but
incorporating AEM in the reaction mixture (Fig. 2). ATRP of AEM
to produce homopolymers has been previously reported;48
thus, AEM monomers were expected to be incorporated into the
polymeric chains randomly and as a function of its reactivity
ratios in the same way as PEGMA and NIPAAm. Diﬀerent
proportions of AEM vs. PEGMA or PNIPAAm were tested. Using
a 3.1% AEM feed ratio with respect to PEGMA, the obtained
dextran–PEGMA–AEM showed a cloud point of 38 C (Fig. 3).
Although various ratios of AEM were tested to synthesize dextran–
PNIPAAm–AEM, none of the obtained PNIPAAm copolymers
showed a demonstrable cloud-point when heated (Fig. 3),
although some temperature-responsiveness was observed using
DLS and AFM (see below). A proportion of 7.1% AEM feed ratio
with respect to PNIPAAm was chosen to evaluate the eﬀect of this
monomer on the polymer uptake by cells. Themolecular weight of
dextran–PNIPAAm–AEM as determined from GPC was apparently
lower than that of dextran–PNIPAAm, being around 72 kDa
(Mw; Mn ¼ 20.8 kDa; Đ ¼ 3.5), suggesting a change in solution
conformation in DMF/LiBr compared to that for the dextran–
PNIPAAm precursor.47RSC Adv., 2017, 7, 14448–14460 | 14453
Fig. 4 Critical micellar concentrations of the diﬀerent dextran
copolymers. I338/I334 ratio of pyrene emission spectra as a function of
the logarithm of the concentration (mg mL1) of dextran–PNIPAAm,
dextran–PNIPAAm–AEM, dextran–PEGMA and dextran–PEGMA–AEM
obtained at 37 C and room temperature (20 C).
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View Article OnlineMicelles characterization
The charges of the copolymers were measured below (25 C) and
above (50 C) the LCST in water. Dextran macroinitiator and
copolymers without AEM were negatively charged at both
temperatures. As expected, AEM copolymers presented positive
charges at 25 C, which were more abundant in dextran–PNI-
PAAm–AEM due to its higher content in AEM (Table 1). The
experiment was also done at 50 C to ensure micelle formation;
in every case the negative or the positive charge was retained at
the higher temperatures.
The self-assembly properties of each copolymer in aqueous
media were evaluated using pyrene as a uorescent probe.
Pyrene solutions in PBS pH 7.4 showed a maximum in uo-
rescence excitation spectra at 338 nm. In the presence of
micelles, pyrene moved from the aqueous environment to the
micelle core and a shi of the mean excitation peak to 334 nm
was observed. To calculate the CMC, the ratio between these two
intensities (I338/I334) was plotted against the logarithm of the
copolymer concentration. The CMC was estimated as the
intersection point between the line that joins the points of at
region and the line that joins the points at the increasing
region49 (Table 1, Fig. 4). The CMC of dextran–PNIPAAm was
estimated to be 80 mg mL1 at 37 C, and no micelle formation
was observed at 20 C in agreement with the hydrophilic char-
acter of both polymers at low temperature.34 This CMC value
was lower than those previously reported for other dextran–
PNIPAm copolymer28 probably because in our case dextran was
of lower molecular weight. The presence of AEM in the copol-
ymer constrained micelle formation, increasing the CMC up to
200 mg mL1 at 37 C, although allowing self-assembly at room
temperature at higher concentrations (CMC ¼ 380 mg mL1).
PEGMA-based copolymers had lower CMCs: 16 mg mL1 for
dextran–PEGMA at both temperatures, and 13 or 16 mg mL1 for
dextran–PEGMA–AEM at 37 and 20 C, respectively. The diﬀer-
ences in CMC between copolymers bearing PNIPAAm and
PEGMA can be attributed to the longer chains of the graed
PEGMA.50 Moreover, the lower CMC values of polymers bearing
PEGMA suggest that micelles may have a better physical
stability against dilution owing to a more hydrophobic core.51 ATable 1 Zeta-potential, CMC and hydrodynamic radius (mass distributio
than one peak) recorded for the macroinitiator and the copolymers
parenthesis, standard deviations
Copolymer LCST (C)
Zeta-potential (mV) C
25 C 50 C 2
DextBr0.4 eq. — 5.7 (4.4) 5.9 (4.3) —
Dextran–PNIPAm 35 3.9 (4.5) 16.6 (4.7) —
Dextran–PNIPAAm–AEM >60 14.8 (3.6) 12.6 (7.1) 3
Dextran–PEGMA 34 22.4 (5.8) 25.7 (7.8) 1
Dextran–PEGMA–AEM 38 6.5 (3.4) 9.3 (5.7) 1
14454 | RSC Adv., 2017, 7, 14448–14460previous work reported on a cellulose derivative bearing PEGMA
chains with even lower CMC (0.12–0.65 mg mL1),47 probably
because of the less hydrophilic character of cellulose compared
to dextran. In the case of oral administration, it has been
pointed out that a CMC lower than 135 mg mL1 is adequate to
prevent rapid dissociation in the gastrointestinal tract and may
provide sustained release/absorption of chemotherapeutics.52
The hydrodynamic diameters were measured using DLS
(Table 2, Fig. S1 in ESI†). The macroinitiator dextBr0.4 eq.
showed a quite small size (2 nm), which slightly increased
with the increase in temperature probably due to minor aggre-
gation. The diameter of dextran–PNIPAAm micelles was around
190 nm at 37 C, and slightly decreased at 55 C. However, at
room temperature aggregates smaller than 20 nm were
observed. The size of these micelles was greater than those
previously reported for other dextran-based copolymer prepared
by ATRP (80–100 nm),36 probably due to diﬀerences in dextran
molecular weight and MS.53 The incorporation of AEM in then in percentage is also indicated in the cases where there were more
solutions (1 mg mL1) at various temperatures. Mean values and, in
MC (mg mL1) Hydrodynamic radius (nm)
0 C 37 C 20 C 37 C 55 C
— 0.99 (0.05) 1.48 (0.06) 2.62 (0.19)
80 8.7 (0.8)–93.9% 88 (21) 80 (10)
52 (8)–6.1%
80 200 4.7 (0.4) 3.8 (0.4)–76%% 4.5 (0.2)–44%
12.3 (2.1)–12% 82 (17)–56%
6 16 8.2 (2.7) 14.1 (0.9)–76% 24.1 (1.5)–87%
190 (42)–24% 306 (48)–13%
6 13 6.5 (1.3) 10.2 (0.5)–91% 367 (48)
321 (68)–9%
This journal is © The Royal Society of Chemistry 2017
Table 2 Loading content (%) and encapsulation eﬃciency (%) of the polymeric micelles prepared applying a dialysis method using PBS pH 7.4 or
phosphate buﬀer pH 5.5 or prepared applying a solvent evaporation method followed by reconstitution using PBS pH 7.4
Copolymer
Loading content (%) Encapsulation eﬃciency (%)
Dialysis method
Evaporation method
(reconstitution at pH 7.4)
Dialysis method
Evaporation method
(reconstitution at pH 7.4)pH 7.4 pH 5.5 pH 7.4 pH 5.5
Dextran 7.4 (1.5) 3.8 (1.5) 0.93 (0.29) 32.4 (1.0) 19.2 (7.5) 4.6 (1.5)
Dextran–PNIPAAm 9.7 (1.1) 5.6 (1.4) 1.9 (0.3) 48.7 (5.6) 27.9 (7.0) 9.3 (1.7)
Dextran–PNIPAAm–AEM 13.5 (0.3) 8.7 (0.2) 2.9 (0.1) 67.5 (1.5) 43.6 (0.9) 14.3 (0.8)
Dextran–PEGMA 6.0 (0.7) 4.6 (0.3) 4.3 (0.8) 30.0 (3.6) 23.3 (1.7) 21.3 (2.4)
Dextran–PEGMA–AEM 15.6 (1.3) 7.5 (2.5) 4.6 (0.2) 77.8 (6.7) 37.7 (1.2) 22.9 (1.2)
Fig. 5 Cell compatibility of the polymers as indicated by metabolic
activity (MTT assay) in BALB/3T3 cells after incubation for 24 h (black
line) and 48 h (red line) with dextran, dextran–PNIPAAm, dextran–
PNIPAAm–AEM, dextran–PEGMA and dextran–PEGMA–AEM at
diﬀerent concentrations.
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View Article Onlinecopolymer led to smaller micelles (around 10 nm) at room
temperature. Upon increasing the temperature, a population of
larger size appeared. Micelles of PEGMA-graed dextrans were
around 20–30 nm at 37 C, in agreement with the data of
previous micelles of PEGMA-graed cellulose.54 The size of the
micelles increased with the temperature as the copolymer
became more hydrophobic and the self-aggregation was facili-
tated.55 It has been previously reported that a suddenly increase
of the temperature may cause a reduction in the size of PEGMA
copolymer micelles.56 Two populations were observed for some
copolymers, probably due to the molecular weight dispersity of
the polysaccharide and the copolymer and diﬀerences in self-
assembly. In any case, micelles were close to or lower than
200 nm at 37 C, which was a key design feature to make them
suitable for in vivo use where they would need to avoid the
recognition by the reticuloendothelial system and to be directed
to tumour tissues by passive targeting.57
AFM images (Fig. S2 in ESI†) corroborated the temperature-
sensitiveness of dextran–PNIPAAm–AEM; particles of 20–25 nm
in diameter at room temperature and of 40–47 nm at 37 C were
observed. The diﬀerences in size when comparing to the DLS
data could be associated to the lower copolymer concentrations
tested in AFM and thus micelles may be formed with less
unimers.
Cytocompatibility of the copolymers was tested against
a murine broblast cell line (BALB/3T3) (Fig. 5), a non-tumour
cell line typically used due to its sensitivity to toxic agents. As
expected, pristine dextran was highly cytocompatible in the
range of concentrations assayed. PEGMA-bearing copolymers
also showed good cytocompatibility (>60%) at 1 mg mL1 aer
48 h of incubation. Cell viability was lowest in the presence of
PNIPAAm-bearing copolymers, although dextran–PNIPAAm
showed an IC50 above 1 mgmL
1 aer 24 h. Dextran–PNIPAAm-
AEM was the most cytotoxic copolymer, with an IC50 around 25
mg mL1 (below the CMC). This toxicity can be associated to its
higher cationic content, in agreement with previous reports that
indicated that AEM polymers have some cytotoxicity.48
Overall, the cytocompatibility results pointed out that
dextran–PEGMA, dextran–PEGMA–AEM and dextran–PNIPAAm
might be safely used as MTX nanocarriers. Although some
cytotoxicity was observed for dextran–PNIPAAm–AEM, this
copolymer was also included in subsequent experiments in
order to compare its performance as an MTX carrier with the
other copolymers.This journal is © The Royal Society of Chemistry 2017Methotrexate-loaded micelles and in vitro drug release
The preparation of micelles loaded with cytostatic drugs
generally involves the dissolution of the polymer and the drug
in an organic solvent, and then, an aqueous buﬀer or water is
added to allow the micelle formation. Aerwards, solvent andRSC Adv., 2017, 7, 14448–14460 | 14455
Fig. 6 MTX release proﬁles from dextran dispersions and polymeric
micelles (7.5 mgmL1) at 37 C in PBS pH 7.4 and phosphate buﬀer pH
5.5. Release proﬁles at 40 C are indicated by triangle symbols and
dash lines.
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View Article Onlinefree drug are removed by dialysis. Dextran micelles graed with
diﬀerent hydrophobic and stimuli-sensitive chains, like poly(-
lactide-co-glycolide), polylactide, polyhistidine or PNIPAAm,
have been shown able to encapsulate diﬀerent amounts of
drugs depending on the nature of the hydrophobic drug and the
polymer chain; the L.C. being between 6 and 13%.26–28,58 In the
case of MTX, L.C. is commonly in the 2–5% range.15,41,42 We
tested two approaches to prepare MTX-loaded micelles. The
dialysis method consisted in adding an excess of MTX to the
copolymer solution followed by incubation at 37 C to promote
the micellisation and subsequent dialysis to remove the non-
encapsulated drug. Two diﬀerent pH values were tested to
check the eﬀect of the AEM on the copolymers. MTX loading
was higher when the pH of the copolymer solutions was set at
7.4, compared to 5.5 (Table 2). At pH 7.4 the carboxylic and the
amine groups of the MTX are deprotonated, presenting a nega-
tive charge, favouring interactions with the AEM co-monomer.
As expected, the L.C. values for the non-ionic copolymers were
similar to those recorded for other drugs in dextran-based
micelles26,58,59 but even using an AEM feed ratio as low as
3.1%, the dextran–PEGMA–AEM copolymers showed much
higher MTX loadings than those previously reported.7,9,10
Controls carried out with dextran revealed that MTX is also
loaded by the pristine polysaccharide, probably through non-
specic hydrophobic interactions as observed for loading of
hydrophobic drugs by other polysaccharides.
A solvent evaporation method was also tested for MTX
encapsulation, using the same copolymer : drug feed ratio as in
the dialysis method. Each copolymer andMTXwere dissolved in
THF and, then, the solvent was allowed to evaporate. The lm
formed was dissolved in PBS pH 7.4 at 37 C and the non-
encapsulated MTX was removed by centrifugation. Lower
encapsulation eﬃciencies and loading contents were recorded
using this approach, although the copolymers ranked in
a similar order to that recorded in the case of the dialysis
method (Table 2). The presence of AEM on the gras slightly
increased the loading by the polymeric micelles, especially in
the case of dextran–PNIPAAm–AEM.
Release studies were carried out in phosphate buﬀer pH 5.5,
which simulates the endosomal pH, and PBS pH 7.4, which
mimics extracellular conditions (Fig. 6).
Pristine dextran dispersions released 60–70% MTX in the
rst 24 h, which indicates that the interaction with the drug was
relatively weak. In contrast, polymeric micelles showed sus-
tained release proles. The highest release rate was recorded for
dextran–PNIPAAm at pH 5.5. Also dextran–PEGMA copolymers
released MTX faster than dextran–PEGMA–AEM counterparts.
In general, the slowest release was observed for copolymers
bearing AEM at pH 5.5, which can be explained by the decrease
in solubility of MTX when partly protonated and the retention of
some ionic interactions with AEM.60 Sustained release from
polymeric micelles was prolonged for more than four days, in
agreement with previous studies carried out with other dextran-
based systems.45
The eﬀect of the temperature on the drug release was also
investigated (Fig. 6). Established solid tumour tissues can
present an increase in temperature of 1–3 C, so the experiment14456 | RSC Adv., 2017, 7, 14448–14460was carried out at 37 C and also 40 C (as a mimic of solid
tumour temperature). These temperatures were above the pre-
dicted LCST for the polymer side-chains, and above the cloud-
points of all the copolymers, except for dextran–PEGMA–AEM.
In our case, both copolymers bearing PNIPAAm released higher
amounts of MTX at 40 C than at 37 C; the increase in release
rate being greater in the case of dextran–PNIPAAm–AEM. It is
known that PNIPAAm chains dehydrate above the LCST61 and
micelles diminish their size as temperature increases (as
observed by means of DLS). Consequently, the collapse of the
micelle may have promoted the release of the drug owing to
diminution of the micellar core volume. On the other hand,
polymers bearing PEGMA showed diﬀerent behavior depending
on the presence or absence of AEM. Dextran–PEGMA micelles
released slightly higher amounts of MTX at 40 C than at 37 C.
DLS data did not show amicelle size reduction with the increase
of the temperature, but this nding may have been due to
aggregation of small micelles.56 In contrast, dextran–PEGMA–This journal is © The Royal Society of Chemistry 2017
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View Article OnlineAEM micelles released higher amounts of MTX at 37 C, which
may have been associated with the more open and less micellar
conformation of this polymer below its cloud point of 38 C.Cytotoxicity of methotrexate-loaded and non-loaded micelles
The bioactivity of MTX-loaded (by dialysis and solvent evapo-
ration methods) and non-loaded micelles was tested against
two cancer cell lines: an ovarian cancer cell line from hamster
(CHOK-1) and adenocarcinoma cells from human cervix (HeLa),
using polymer concentrations equal to two-fold CMC (Fig. 7).
Dextran was tested at the highest concentration used (400 mg
mL1) and the results conrmed its excellent cytocompatibility.
All non-loaded micelles, except those prepared with dextran–
PNIPAAm-AEM, were highly cytocompatible with the tumour
cells. In the case of MTX-loaded micelles, dextran–PNIPAAm,
dextran–PEGMA and dextran–PEGMA–AEM, the presence of
MTX slightly increased the cytotoxicity of the micelles particu-
larly aer 48 h of incubation with both cell lines. In addition,
they were more cytotoxic than a solution of free MTX prepared
with a drug concentration higher than that provided by any of
the micelle formulations. In the case of CHO-K1 and for a given
copolymer, the performance of the drug-loaded polymeric
micelles was similar independent of the loading method.
However, in HeLa cells, dextran–PEGMA and dextran–PEGMA–
AEM micelles, loaded via the dialysis method, were more cyto-
toxic due to the higher amount of MTX encapsulated. By
contrast, dextran–PNIPAAm micelles were more cytotoxic when
they were loaded applying the evaporation method. In general,
HeLa cells were less sensitive to MTX than CHO-K1 cells, as
observed for the control drug solution.
Dextran–PNIPAAM–AEM micelles were cytotoxic in the
absence of the cytostatic agent. Aer MTX encapsulation, theFig. 7 Cytotoxicity of the MTX-loaded and empty micelles against
tumour cells. Viability of CHO-K1 and HeLa cells after incubation with
placebo dextran (400 mg mL1), dextran–PNIPAAm (320 mg mL1),
dextran–PNIPAAm–AEM (400 mgmL1), dextran–PEGMA (32 mgmL1)
and dextran–PEGMA–AEM (26 mg mL1) micelles and the corre-
sponding MTX-loaded micelles prepared applying dialysis (DM) and
solvent evaporation (EM) methods.
This journal is © The Royal Society of Chemistry 2017toxicity of the micelles diminished. This behavior could be due
to the interaction of MTX with the AEM groups, which in turn
diminished the number of free cationic amine groups respon-
sible for the cytotoxicity of the copolymer. A similar nding has
been previously reported for complexes of poly(2-dimethyl
amino ethyl methacrylate) with DNA, which were less cyto-
toxic than the polymer itself.46
Regarding dextran controls, aer 48 h of incubation, MTX-
loaded dextran system caused higher cytotoxicity than freeFig. 8 Cellular internalization of FITC-labeled micelles by CHO-K1
after 2 h of incubation with cells by confocal microscopy. (A) Dextran–
PNIPAAm at 160 mgmL1 and (B) 500 mgmL1, (C) dextran–PNIPAAm–
AEM at 400 mgmL1 and (D) 500 mgmL1, (E) dextran–PEGMA at 32 mg
mL1 and (F) 500 mg mL1 and (G) dextran–PEGMA–AEM at 26 mg
mL1 and (H) 500 mg mL1. Blue channel corresponds to the nucleus
dyed with DAPI, red channel the cytoskeleton stained with phalloidin
and green channel the micelles labeled with FITC. Scale bar 25 mm.
RSC Adv., 2017, 7, 14448–14460 | 14457
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View Article OnlineMTX, which may suggest a possible cellular uptake of MTX
promoted by the free dextran. Overall, both loading methods
proved suitable for the preparation of MTX-loaded micelles as
cytotoxicity eﬀects were dependent on the copolymer type and
the cell susceptibility.Cellular uptake
The uptake of the polymeric micelles by CHO-K1 cells was
monitored by means of confocal microscopy (Fig. 8 and 9). Cells
were incubated with non-loaded FITC-labelled micelles over 2
and 24 h and confocal images were recorded. The cells did not
modify their morphology, as compared with the negative
control (Fig. 9.1). The highest cellular uptake was observed for
dextran–PNIPAAm–AEM (Fig. 8C and D and 9.3) at both
concentrations tested (400 mg mL1 and 500 mg mL1), which
was likely due to the high AEM content in the copolymer which
enhanced cell membrane interaction and internalization.38
Moreover, this fast internalization could destabilize the ionicFig. 9 Cellular internalization of the micelles by CHO-K1 after 24 h of inc
FTIC-labeled polymeric micelles (500 mg mL1) of dextran–PNIPAAm
PEGMA–AEM (5). (A) Blue channel, the nucleus dyed with DAPI; (B) red ch
micelles labeled with FITC and (D) all merged. Scale bar 20 mm.
14458 | RSC Adv., 2017, 7, 14448–14460balance and the structure of the membrane, which in turn may
have been a reason for the high cytotoxicity of these micelles.
Dextran–PNIPAAm (Fig. 8A), dextran–PEGMA (Fig. 8E) and
dextran–PEGMA–AEM (Fig. 8G) were almost not internalized by
the CHO-K1 cells at the lower concentration tested (2-fold CMC)
probably due to the short time in contact with cells and the low
copolymer concentration used (26–160 mg mL1).
The experiments were repeated testing all copolymers at the
same concentration (500 mg mL1). At this higher concentra-
tion, micelles of dextran–PNIPAAm, dextran–PEGMA and
dextran–PEGMA–AEM were internalized to a low extent again
(Fig. 8B, F and H). This nding is in agreement with previous
reports that demonstrate that PEGMA-based copolymers are
barely internalized in HeLa cells aer 2 h of incubation if no
internalising ligand is used to enhance the uptake.60 The low
AEM proportion present in dextran–PEGMA–AEM seemed to be
not enough to enhance the cellular uptake.
To evaluate the cellular internalization, confocal images
were taken in two planes of the cells containing micelles.ubation with cells by confocal microscopy. (1) Fresh medium and (2–5)
(2), dextran–PNIPAAm–AEM (3), dextran–PEGMA (4) and dextran–
annel, the cytoskeleton stained with phalloidin; (C) green channel, the
This journal is © The Royal Society of Chemistry 2017
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View Article OnlineMicelles, that are represented in the green channel due to the
conjugation of the polymers with FITC, could be detected
between the cytoplasm (red channel) and the nucleus of cells
(blue channel). MTX-loaded dextran–PNIPAAm, dextran–
PEGMA and dextran–PEGMA–AEM demonstrated their cyto-
toxic eﬀects aer 24 and 48 h of incubation with CHO-K1 cells
when a concentration of twice the CMC was used. We hypoth-
esised that the short time of the incubation for confocal studies
was the reason for the low internalization observed, and further
studies aer 24 h of incubation with cells were carried out
(Fig. 9). More micelles were internalized with the increase of the
incubation time. A higher internalization was observed with the
incorporation of AEM into the copolymers, especially in the case
of dextran–PNIPAAm–AEM. Interestingly, in the case of PEGMA
copolymers the micelles were colocalized in the cytoplasm as
the green colour from the micelles turned to yellow when it is
colocalized with the red colour from the cytoskeleton dyed with
phalloidin.Conclusions
Copolymers of dextran and PNIPAAm or PEGMA were success-
fully prepared by conducting free radical polymerisations from
initiator sites on the dextran backbone, without the require-
ment of protecting the hydroxyl groups. To overcome the
common limitation of micelles for achieving high MTX loading
capacities, a monomer with amine groups (AEM) was also
successfully incorporated on the polymer chains. Micelles ob-
tained showed an appropriate size for being internalized by
cells and were able to encapsulate a hydrophobic probe in their
nuclei. In addition, except for the case of dextran–PNIPAAm–
AEM, the copolymers were very cytocompatible in non-tumoural
mammalian cells at concentrations up to 0.1 mg mL1. MTX-
loaded polymeric micelles showed pH- and temperature-
responsive release and were slowly internalized into tumour
cells, being more cytotoxic than solutions of the free drug. AEM
in the chains graed to the dextran enhanced cellular uptake.
Overall the results indicate that an adequate balance in the
proportion of temperature-sensitive graed chains and of AEM
moieties may lead to dextran-based polymeric micelles suitable
as MTX nanocarriers.Acknowledgements
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